XML 37 R26.htm IDEA: XBRL DOCUMENT

SUPPLEMENTAL EQUITY INFORMATION (Tables)

3 Months Ended

Mar. 31, 2019

Schedule of components of accumulated other comprehensive loss, net of tax


			Other
	Minimum		Comprehensive
	Pension and		Loss
	Post-		Related to
	Retirement		Equity
(in thousands)	Liability		Investments		Total
Balance at December 30, 2018	$	(595,820)	$	(8,469)	$	(604,289)
Other comprehensive income (loss) before reclassifications		17,745		—		17,745
Amounts reclassified from AOCL		4,807		—		4,807
Other comprehensive income		22,552		—		22,552
Balance at March 31, 2019	$	(573,268)	$	(8,469)	$	(581,737)

Schedule of reclassification out of accumulated other comprehensive income


	Amount Reclassified from AOCL
	Three Months Ended
(in thousands)	March 31,		April 1,		Affected Line in the Condensed
AOCL Component	2019		2018		Consolidated Statements of Operations
Minimum pension and post-retirement liability	$	4,807	$	5,550	Retirement benefit expense (1)

_____________________

(1) There is no income tax benefit associated with the three months ended March 31, 2019, or April 1, 2018, due to the recognition of a valuation allowance.

Summary of the restricted stock units ("RSUs") activity


		Weighted
		Average Grant
		Date Fair
	RSUs	Value
Nonvested — December 30, 2018	331,600	$	9.56
Granted	285,771	$	5.58
Vested	(164,042)	$	9.68
Forfeited	(2,920)	$	9.30
Nonvested — March 31, 2019	450,409	$	6.99

Summary of the stock appreciation rights ("SARs") activity

The following table summarizes the stock appreciation rights (“SARs”) activity during the three months ended March 31, 2019:


		Weighted		Aggregate
		Average		Intrinsic Value
	SARs	Exercise Price		(in thousands)
Outstanding December 30, 2018	113,300	$	32.13	$	—
Expired	(4,000)	$	34.20
Outstanding March 31, 2019	109,300	$	32.05	$	—

Summary of stock-based compensation expense


	Three Months Ended
	March 31,		April 1,
(in thousands)	2019		2018
Stock-based compensation expense	$	663	$	741

Summary of anti-dilutive stock options


	Quarters Ended
	March 31,	April 1,
(shares in thousands)	2019	2018
Anti-dilutive common stock equivalents	160	224